ArticleGynecologic oncology reports2025

Etoposide combined with anlotinib and sintilimab successfully achieved long term progression-free survival in platinum-refractory ovarian cancer: A case report.

Luying Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.